+

WO2006067327A3 - Benzodiazepine peripheral receptor antagonists for treating dry skin - Google Patents

Benzodiazepine peripheral receptor antagonists for treating dry skin Download PDF

Info

Publication number
WO2006067327A3
WO2006067327A3 PCT/FR2005/003198 FR2005003198W WO2006067327A3 WO 2006067327 A3 WO2006067327 A3 WO 2006067327A3 FR 2005003198 W FR2005003198 W FR 2005003198W WO 2006067327 A3 WO2006067327 A3 WO 2006067327A3
Authority
WO
WIPO (PCT)
Prior art keywords
dry skin
receptor antagonists
treating dry
peripheral receptor
treating
Prior art date
Application number
PCT/FR2005/003198
Other languages
French (fr)
Other versions
WO2006067327A2 (en
Inventor
Maria Dalko
Original Assignee
Oreal
Maria Dalko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0453082A external-priority patent/FR2879450B1/en
Application filed by Oreal, Maria Dalko filed Critical Oreal
Publication of WO2006067327A2 publication Critical patent/WO2006067327A2/en
Publication of WO2006067327A3 publication Critical patent/WO2006067327A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the use of a composition containing at least one benzodiazepine peripheral receptor antagonist (PBR) for treating dry skin or dry scalps. Said composition can be used for cosmetic purposes, for treating the drying of the skin, especially after the menopause, or for dermatological purposes, for treating disorders related to oligoseborrheic dry skin, especially dermatitis.
PCT/FR2005/003198 2004-12-20 2005-12-20 Benzodiazepine peripheral receptor antagonists for treating dry skin WO2006067327A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0453082 2004-12-20
FR0453082A FR2879450B1 (en) 2004-12-20 2004-12-20 ANTAGONISTS OF PERIPHERAL RECEPTORS OF BENZODIAZEPINES FOR THE TREATMENT OF DRY SKINS
US64142605P 2005-01-06 2005-01-06
US60/641,426 2005-01-06

Publications (2)

Publication Number Publication Date
WO2006067327A2 WO2006067327A2 (en) 2006-06-29
WO2006067327A3 true WO2006067327A3 (en) 2007-03-01

Family

ID=36487604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/003198 WO2006067327A2 (en) 2004-12-20 2005-12-20 Benzodiazepine peripheral receptor antagonists for treating dry skin

Country Status (1)

Country Link
WO (1) WO2006067327A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758783B1 (en) 2012-12-20 2014-06-24 L'oreal Water-in-oil emulsion comprising pigments in the water phase
CN110194808B (en) * 2019-06-12 2021-08-31 北京果素堂生物科技有限公司 Plant refined polysaccharide and application thereof in preparation of whitening cosmetics
CN113456514B (en) * 2021-08-16 2023-05-26 华熙生物科技股份有限公司 Scalp care composition containing hyaluronic acid and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001082877A2 (en) * 2000-05-04 2001-11-08 Basf Aktiengesellschaft Use of parp inhibitors in cosmetic preparations
FR2811897A1 (en) * 2000-07-24 2002-01-25 Sanofi Synthelabo Treatment of diseases associated with peripheral benzodiazepine receptor dysfunction, e.g. peripheral neuropathy, cardiac insufficiency or cancer, using pyridazino(4,5-b)indole-1-acetamide derivatives
US6572848B1 (en) * 1997-09-01 2003-06-03 Societe L'oreal S.A. Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
US6767533B1 (en) * 1998-11-17 2004-07-27 Sanofi-Synthelabo Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
EP1475368A1 (en) * 2002-02-14 2004-11-10 Ono Pharmaceutical Co., Ltd. N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572848B1 (en) * 1997-09-01 2003-06-03 Societe L'oreal S.A. Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
US6767533B1 (en) * 1998-11-17 2004-07-27 Sanofi-Synthelabo Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
WO2001082877A2 (en) * 2000-05-04 2001-11-08 Basf Aktiengesellschaft Use of parp inhibitors in cosmetic preparations
FR2811897A1 (en) * 2000-07-24 2002-01-25 Sanofi Synthelabo Treatment of diseases associated with peripheral benzodiazepine receptor dysfunction, e.g. peripheral neuropathy, cardiac insufficiency or cancer, using pyridazino(4,5-b)indole-1-acetamide derivatives
EP1475368A1 (en) * 2002-02-14 2004-11-10 Ono Pharmaceutical Co., Ltd. N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ORMEN F ET AL: "RICERCHE PRELIMINARI CLINICO-PSICOLOGICHE SU DI UN NUOVO DERIVATO BENZODIAZEPINICO (NOBRIUM) IN DERMATOLOGIA", GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, TURIN, IT, vol. 45, no. 5, 1970, pages 325 - 339, XP000878885, ISSN: 0392-0488 *

Also Published As

Publication number Publication date
WO2006067327A2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
WO2007022257A3 (en) Monocyclic and bicyclic compounds and methods of use
WO2007039058A3 (en) Use of opioid receptor antagonists
SI1761266T1 (en) Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
WO2007073432A3 (en) Piperidine derivatives and methods of use
EP2043630A4 (en) 6,9-DISUBSTITUTED PURINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN
PH12012500809A1 (en) Methods and compositions for treating cancer
CR8642A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
WO2006058236A3 (en) Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
HUE039348T2 (en) A2A receptor antagonists for use in the treatment of movement disorders
EP1727530A4 (en) Topical formulations for the treatment of skin conditions
MX291850B (en) An oil-in-water emulsion composition for wet wipes which is gentle to the skin.
BRPI0615163A2 (en) compound, pharmaceutical composition, use of the compound, and methods for treating mglur5-mediated disorders and for inhibiting activation of mglur5 receptors
CL2013001885A1 (en) Compounds derived from morphine, peripheral ipiode receptor antagonists; pharmaceutical composition; oral formulation; and use to reduce the side effects of opioid therapy (div. sol. 905-08).
WO2006018024A3 (en) Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
WO2005112916A3 (en) Bis-aryl sulfonamides
IL184048A0 (en) Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
IS8105A (en) A pharmaceutical composition including an immunosuppressant for use in the treatment of skin disorders
ZA200711041B (en) Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2006135694A3 (en) Uii-modulating compounds and their use
WO2006020680A3 (en) Heterocyclic compounds as pharmaceutical agents
EP1879027A4 (en) Agent for preventing and treating pancreatitis
EP1751175A4 (en) Interleukin-1 receptor antagonists, compositions, and methods of treatment
WO2007024752A3 (en) Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
WO2006067327A3 (en) Benzodiazepine peripheral receptor antagonists for treating dry skin
ZA200703060B (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to odulation of the dopamine d3 receptor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05850547

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载